01 1CTX Lifesciences
01 1ACETAZOLAMIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-09
Pay. Date : 2012-12-10
DMF Number : 23014
Submission : 2009-07-31
Status : Active
Type : II
20
Ctx Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ACETAZOLAMIDE USP, with a corresponding US DMF Number 23014.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 10, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
